Nureca Ltd.
Snapshot View

996.90 +12.00 ▲1.2%

24 June 2022, 04:01:00 PM
Volume: 647

Overview View Details

Sector Healthcare Compare with Sector peers
Industry Medical Equipment/Supplies/Accessories Compare with Industry peers
Website http://www.nureca.com
Market Cap 992.27 Cr.
Enterprise Value(EV) 912.64 Cr. 2022-03
Financial Indicators
Earnings per share (EPS) 44.96 Trailing Twelve Months Ending 2022-03
Price-Earning Ratio (PE) 22.17 Trailing Twelve Months Ending 2022-03
Industry PE 42.47 Trailing Twelve Months Ending 2022-03
Book Value / Share 203.19 Trailing Twelve Months Ending 2022-03
Price to Book Value 4.91 Calculated using Price: 996.90
Dividend Yield 0.20 Period Ending 2021-03
No. of Shares Subscribed 1.00 Cr. 10,000,175 Shares
FaceValue 10
Company Profile
Nureca is a B2C company engaged in the business of home healthcare and wellness products, which offers quality, durability, functionality, usability and innovative designs. It enables its customers with tools to help them monitor chronic ailments and other diseases, to improve their lifestyle. It is a digital first company wherein it sells its products through online channel partners such as e-commerce players, distributors and retailer. Further, it also sells its products through its own website drtrust.in.

Delivery View Details

Delivered Qty
Traded Qty

Performance View Details

1 Day
+1.22%
1 Week
+4.08%
1 Month
-7.92%
3 Month
-28.41%
6 Month
-29.44%
1 Year
-38.75%
2 Year
5 Year
10 Year
4 years 2018-03 2019-03 2020-03 2021-03
Return on Equity (%) 426.30 162.03 61.23 52.39
Return on Capital Employed (%) 255.06 179.97 56.70 66.70
Return on Assets (%) 44.35 40.78 22.30 39.61

Balance Sheet View Details

Particulars 5 years 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03* Rs. Cr.
Shh. Funds 2 8 15 163 203
Non Curr. Liab. 0 0 9 3 4
Curr. Liab. 5 15 10 34 12
Minority Int.
Equity & Liab. 7 24 34 200 219
Non Curr. Assets 0 1 1 4 13
Curr. Assets 7 23 33 196 206
Misc. Exp. not W/O
Total Assets 7 24 34 200 219

Profit Loss View Details

Particulars 5 years 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. TTM
Net Sales 20 62 99 213 256
Other Income 0 0 0 3 8
Total Income 20 62 99 216 263
Total Expenditure -16 -53 -90 -152 -200
PBIDT 4 9 10 64 63
Interest 0 0 -1 -2 -1
Depreciation 0 0 0 0 -1
Taxation -1 -3 -2 -16 -16
Exceptional Items
PAT 3 6 6 46 45
Minority Interest
Share Associate
Other Related Items
Consolidated Net Profit 3 6 6 46 45
Adjusted EPS 445 889 914 46 45

Cash Flow View Details

Particulars 4 years 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr.
Cash Fr. Operatn. 0 0 -8 35
Cash Fr. Inv. 0 0 0 -110
Cash Fr. Finan. 0 0 8 92
Net Change 0 0 0 17
Cash & Cash Eqvt 0 0 0 17

Shareholding Pattern View Details

5 Qtrs 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%)
Promoter 70.00 70.00 70.00 70.00 70.00
Public 30.00 30.00 30.00 30.00 30.00
Depository Receipts 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00

Announcements View Details

Wed, 22 Jun 2022
Closure of Trading Window
Trading Window for dealing in the equity shares of the Company will remain closed from June 23 2022 (Thursday) till the completion of 48 hours after the declaration of unaudited financial results of the Company for the quarter ending on June 30 2022.
Tue, 21 Jun 2022
Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper Advertisement in connection with the 6th Annual General Meeting (AGM) of the Company
Sat, 11 Jun 2022
Related Party Transactions For The Half-Year Ended March 31 2022
Related Party Transactions for the half-year ended March 31 2022

Technical Scans View Details

Fri, 24 Jun 2022
Close Within 52 Week Low Zone Close Within 52 Week Low Zone
High Decrease 1 Month High Decrease 1 Month
High Decrease 3 Months High Decrease 3 Months
High Decrease 6 Months High Decrease 6 Months
High Decrease 1 Year High Decrease 1 Year

Related Stocks View Details

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 197,729.19 824.10 -0.1%
Divi's Laboratories Ltd. 97,465.46 3,671.45 +0.1%
Cipla Ltd. 75,288.48 933.05 +0.0%
Dr. Reddy's Laboratories Ltd. 71,702.79 4,308.00 +0.3%
Apollo Hospitals Enterprise Ltd. 55,150.04 3,835.60 -0.4%
Torrent Pharmaceuticals Ltd. 48,693.19 2,877.70 +0.8%
Gland Pharma Ltd. 42,987.55 2,610.75 +0.1%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 60.42 824.10 -0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 32.92 3,671.45 +0.1%
Cipla Ltd. Consolidated 2022-03 29.92 933.05 +0.0%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 32.85 4,308.00 +0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 52.24 3,835.60 -0.4%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 62.67 2,877.70 +0.8%
Gland Pharma Ltd. Consolidated 2022-03 35.48 2,610.75 +0.1%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 4.12 824.10 -0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 8.31 3,671.45 +0.1%
Cipla Ltd. Consolidated 2022-03 3.61 933.05 +0.0%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 3.73 4,308.00 +0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 9.78 3,835.60 -0.4%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8.18 2,877.70 +0.8%
Gland Pharma Ltd. Consolidated 2022-03 6.01 2,610.75 +0.1%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2021-03 0.08 824.10 -0.1%
Divi's Laboratories Ltd. Consolidated 2021-03 0.00 3,671.45 +0.1%
Cipla Ltd. Consolidated 2021-03 0.10 933.05 +0.0%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-03 0.17 4,308.00 +0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2021-03 0.62 3,835.60 -0.4%
Torrent Pharmaceuticals Ltd. Consolidated 2021-03 0.84 2,877.70 +0.8%
Gland Pharma Ltd. Consolidated 2021-03 0.00 2,610.75 +0.1%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2021-03 4.98 824.10 -0.1%
Divi's Laboratories Ltd. Consolidated 2021-03 23.90 3,671.45 +0.1%
Cipla Ltd. Consolidated 2021-03 14.13 933.05 +0.0%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-03 11.53 4,308.00 +0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2021-03 3.44 3,835.60 -0.4%
Torrent Pharmaceuticals Ltd. Consolidated 2021-03 23.49 2,877.70 +0.8%
Gland Pharma Ltd. Consolidated 2021-03 20.97 2,610.75 +0.1%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2021-03 4.98 824.10 -0.1%
Divi's Laboratories Ltd. Consolidated 2021-03 23.90 3,671.45 +0.1%
Cipla Ltd. Consolidated 2021-03 14.13 933.05 +0.0%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-03 11.53 4,308.00 +0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2021-03 3.44 3,835.60 -0.4%
Torrent Pharmaceuticals Ltd. Consolidated 2021-03 23.49 2,877.70 +0.8%
Gland Pharma Ltd. Consolidated 2021-03 20.97 2,610.75 +0.1%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2021-03 33,498.14 824.10 -0.1%
Divi's Laboratories Ltd. Consolidated 2021-03 6,969.40 3,671.45 +0.1%
Cipla Ltd. Consolidated 2021-03 19,159.59 933.05 +0.0%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-03 19,047.50 4,308.00 +0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2021-03 10,560.00 3,835.60 -0.4%
Torrent Pharmaceuticals Ltd. Consolidated 2021-03 8,004.83 2,877.70 +0.8%
Gland Pharma Ltd. Consolidated 2021-03 3,462.88 2,610.75 +0.1%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2021-03 2,284.68 824.10 -0.1%
Divi's Laboratories Ltd. Consolidated 2021-03 1,984.29 3,671.45 +0.1%
Cipla Ltd. Consolidated 2021-03 2,401.30 933.05 +0.0%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-03 1,903.60 4,308.00 +0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2021-03 136.00 3,835.60 -0.4%
Torrent Pharmaceuticals Ltd. Consolidated 2021-03 1,251.88 2,877.70 +0.8%
Gland Pharma Ltd. Consolidated 2021-03 996.96 2,610.75 +0.1%

FAQ's On Nureca Ltd.

Can I Buy Nureca Ltd. Shares now?

What is the Share Price of Nureca Ltd.?

What is the Relative Strength Index (RSI) Value of Nureca Ltd.?

What is the Market Capital (MCAP) of Nureca Ltd.?

What are the key metrics to analyse Nureca Ltd.?

What is the Price Performance of Nureca Ltd.?